The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for SE Webber


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.EBI
Anadys Pharmaceuticals
Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.EBI
Pfizer
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors.EBI
University of Newcastle
Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors.EBI
Pfizer
Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.EBI
Pfizer
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.EBI
Agouron Pharmaceuticals
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.EBI
Agouron Pharmaceuticals
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.EBI
Agouron Pharmaceuticals
Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.EBI
Agouron Pharmaceuticals
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease.EBI
Agouron Pharmaceuticals
Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones.EBI
Agouron Pharmaceuticals
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.EBI
Effector Therapeutics
Perspectives on SARS-CoV-2 Main Protease Inhibitors.BDB
Michigan State University
Disubstituted compounds for treatment of medical disordersBDB
Achillion Pharmaceuticals
Substituted 7-azabicycles and their use as orexin receptor modulatorsBDB
Janssen Pharmaceutica
Substituted pyrrolopyrimidines as HDM2 inhibitorsBDB
Merck Sharp & Dohme
Heterocyclic compounds as inhibitors of class I PI3KSBDB
TBA
Purinone compounds as kinase inhibitorsBDB
Pharmacyclics
Btk inhibitorsBDB
Merck Sharp & Dohme
Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereofBDB
Shanghai Hengrui Pharmaceutical
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsBDB
Merck Sharp & Dohme
Amide or urea containing benzothiazole inhibitors of endothelial lipaseBDB
Bristol-Myers Squibb
Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.BDB
Birla Institute of Technology